TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
IMA

ImageneBio, Inc.

Healthcare · Biotechnology

5.00$ +1.8% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns ImageneBio, Inc. (IMA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 51.5% of the shares are freely tradable; institutional investors hold 55.5%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 55.5%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 15.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 51.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 0.4%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 11Mio.

Largest Shareholders

Institutions

Institutions IMA
Name Stake (%) Shares Change (%) Date
Bvf Inc 9.84 1,110,002 +38.4 03/31/2026
Blue Owl Capital Holdings LP 8.14 917,692 -4.3 06/30/2026
Cable Car Capital LLC 6.69 754,749 +17.2 03/31/2026
Omega Fund Management LLC 4.04 455,361 +0.0 03/31/2026
Orbimed Advisors LLC 3.36 378,556 +0.0 03/31/2026
RTW INVESTMENTS, LLC 2.97 334,445 +0.0 03/31/2026
Vanguard Capital Management, LLC 2.88 325,155 +0.0 03/31/2026
Trails Edge Capital Partners, LP 2.50 282,004 +0.0 06/30/2026
BML Capital Management LLC 1.78 200,730 +0.0 06/30/2026

Funds

Funds IMA
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.35 264,771 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings IMA
Person Role Shares Value As of Type
Yarema Kristin Chief Executive Officer 493,705 2,468,525 $ Aug 14, 2026 direct
Grant-Huerta Yanina Chief Financial Officer 104,000 520,000 $ Aug 14, 2026 direct
Lally Robert B Principal Accounting Officer 55,582 277,910 $ Jul 17, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 14, 2026 Grant-Huerta Yanina Chief Financial Officer Other 39,000 0.00
Aug 14, 2026 Grant-Huerta Yanina Chief Financial Officer Other 65,000 0.00
Aug 14, 2026 Yarema Kristin Chief Executive Officer Other 254,800 0.00
Jul 25, 2026 Yarema Kristin Chief Executive Officer Other 115,129 0.00
Jul 25, 2026 Yarema Kristin Chief Executive Officer Other 38,376 0.00
Jul 17, 2026 Lally Robert B Principal Accounting Officer Sell 1,525 5.34 8,144
Jul 16, 2026 Lally Robert B Principal Accounting Officer Sell 1,671 5.50 9,191

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?